Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Quality of Life × Oxaliplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 15 Stomach Neoplasms 11 Colonic Neoplasms 7 Carcinoma, Hepatocellular 5 Rectal Neoplasms 4 Pancreatic Neoplasms 3 Neoplasms 3 Biliary Tract Neoplasms 3 Lymphoma, Large B-Cell, Diffuse 2 Gastrointestinal Neoplasms 2 Gallbladder Neoplasms 2 Adenocarcinoma 2 Vipoma 1 Somatostatinoma 1 Resected Liver Metastases From Colorectal Cancer 1 Recurrence 1 Quality of Life 1 Pathologic Complete Response 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Liver Neoplasms 1 Insulinoma 1 HER2-positive Gastric Cancer 1 Glucagonoma 1 Gastroesophageal Junction Adenocarcinoma 1 Gastrinoma 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1

Interventions

endostar protein 1 Oxaliplatin 1 Chemoradiotherapy 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03577392 2019-04-04

EXECC

Sichuan Provincial People's Hospital

Phase 2/3 Unknown

Quality of Life

Data powered by HemOnc (CC BY 4.0) Colophon ⚡